Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06383247 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkinson's Disease

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Apr 17, 2025, no change to tracked fieldsv4-v5
  2. Trial status: Not Yet Recruiting to Recruitingv3 Show 8 more changesShow less
    • Primary completion date: Dec 31, 2028 to Dec 31, 2026
    • Enrollment target: 312 to 290
    • Study completion date: Dec 31, 2030 to Dec 31, 2028
    • Start date changed from estimate of Nov 1, 2024 to Dec 6, 2024
    • Eligibility criteria expanded, about 44 words
    • Secondary endpoints: 3 to 13
    • Site details revised
    • Study title expanded, about 4 words
  3. Study description revised
    • Study title shortened, about 6 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive and widely used neuromodulation technology. Small sample studies have shown that rTMS treatment can significantly improve the symptoms of Parkinson's disease(PD) and delay the progression of the disease. In order to further explore the effectiveness of rTMS in the treatment of PD and lay the foundation for its clinical promotion, our research team plans to conduct a randomized double-blind controlled study of rTMS in the treatment of PD in multiple centers across the country.
Trial Details
NCT Number NCT06383247
Lead Sponsor Anhui Medical University
Conditions
(from sponsor)		 Parkinson Disease, Transcranial Magenetic Stimualtion, Supplementary Motor Area
Related terms Parkinson Disease
Enrollment 290 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov